Header links
Intranet
Donate now
image/svg+xml Map
Contact us

Publications

Publications searcher

The science produced by our scientists is very important. In 2024, 1,501 papers were published in scientific journals with an average impact factor of over 7.13 points.

Fetuin-A, inter-alpha-trypsin inhibitor, glutamic acid and ChoE (18:0) are key biomarkers in a panel distinguishing mild from critical coronavirus disease 2019 outcomes.

PMID: 35075803
Journal: Clinical and Translational Medicine
Year: 2022
Reference: Clin Transl Med. 2022 Jan;12(1):e704. doi: 10.1002/ctm2.704.
Impact factor:
Publication type: Letter whit IF
Authors: Auguet, Teresa; Benavent-Bofill, Clara; Boque, Carme; Burgos, Joaquin; Buzon, Maria Jose; Garcia-Pardo, Graciano; Gomez-Bertomeu, Frederic; Gutierrez-Valencia, Alicia; Lopez-Cortes, Luis F; Marti, Anna et al.
DOI: 10.1002/ctm2.704

Fidaxomicin monotherapy versus standard therapy combined with bezlotoxumab for treating patients with Clostridioides difficile infection at high risk of recurrence: a matched cohort study.

PMID: 35403189
Journal: JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
Year: 2022
Reference: J Antimicrob Chemother. 2022 Jun 29;77(7):1996-2002. doi: 10.1093/jac/dkac106.
Impact factor: 5.79
Publication type: Paper in international publication
Authors: Cobo Reinoso, Javier, Lopez Medrano, Francisco, De La Torre Cisneros, Julian, Gutierrez, Belen, Escudero-Sanchez, Rosa, Muriel Garcia, Alfonso, Garcia Fernandez, Sergio, Valencia Alijo, Angela, Tasias Pitarch, Mariona, Merino De Lucas, Esperanza et al.
DOI: 10.1093/jac/dkac106

Fidaxomicin monotherapy versus standard therapy combined with bezlotoxumab for treating patients with Clostridioides difficile infection at high risk of recurrence: a matched cohort study.

PMID: 35403189
Journal: JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
Year: 2022
Reference: J Antimicrob Chemother. 2022 Jun 29;77(7):1996-2002. doi: 10.1093/jac/dkac106.
Impact factor:
Publication type: Paper in international publication
Authors: Arminanzas Castillo, Carlos; Cano Yuste, Angela; Cobo Reinoso, Javier; De La Torre Cisneros, Julian; Diaz Pollan, Beatriz; Escudero-Sanchez, Rosa; Fernandez Fradejas, Jorge; Garcia Basas, Lorena; Garcia Fernandez, Sergio; Giner, Livia et al.
DOI: 10.1093/jac/dkac106

Final Overall Survival and Molecular Analysis in IMmotion151, a Phase 3 Trial Comparing Atezolizumab Plus Bevacizumab vs Sunitinib in Patients With Previously Untreated Metastatic Renal Cell Carcinoma.

PMID: 34940781
Journal: JAMA Oncology
Year: 2022
Reference: JAMA Oncol. 2022 Feb 1;8(2):275-280. doi: 10.1001/jamaoncol.2021.5981.
Impact factor: 31.777
Publication type: Paper in international publication
Authors: Motzer, Robert J, Powles, Thomas, Atkins, Michael B, Escudier, Bernard, McDermott, David F, Alekseev, Boris Y, Lee, Jae-Lyun, Suarez, Cristina, Stroyakovskiy, Daniil, De Giorgi, Ugo et al.
DOI: 10.1001/jamaoncol.2021.5981

Final Overall Survival and Molecular Analysis in IMmotion151, a Phase 3 Trial Comparing Atezolizumab Plus Bevacizumab vs Sunitinib in Patients With Previously Untreated Metastatic Renal Cell Carcinoma.

PMID: 34940781
Journal: JAMA Oncology
Year: 2022
Reference: JAMA Oncol. 2022 Feb 1;8(2):275-280. doi: 10.1001/jamaoncol.2021.5981.
Impact factor:
Publication type: Paper in international publication
Authors: Alekseev, Boris Y; Atkins, Michael B; Banchereau, Romain; Craine, Veronica; De Giorgi, Ugo; Donskov, Frede; Dubey, Sarita; Escudier, Bernard; Flinn, Nick; Hamidi, Habib et al.
DOI: 10.1001/jamaoncol.2021.5981

Final Results of Neoadjuvant Atezolizumab in Cisplatin-ineligible Patients with Muscle-invasive Urothelial Cancer of the Bladder.

PMID: 35577646
Journal: EUROPEAN UROLOGY
Year: 2022
Reference: Eur Urol. 2022 Aug;82(2):212-222. doi: 10.1016/j.eururo.2022.04.013. Epub 2022 May 14.
Impact factor: 20.096
Publication type: Paper in international publication
Authors: Szabados, Bernadett, Kockx, Mark, Assaf, Zoe June, van Dam, Pieter-Jan, Rodriguez-Vida, Alejo, Duran, Ignacio, Crabb, Simon J, Van Der Heijden, Michiel S, Pous, Albert Font, Gravis, Gwenaelle et al.
DOI: 10.1016/j.eururo.2022.04.013

Final Results of Neoadjuvant Atezolizumab in Cisplatin-ineligible Patients with Muscle-invasive Urothelial Cancer of the Bladder.

PMID: 35577646
Journal: EUROPEAN UROLOGY
Year: 2022
Reference: Eur Urol. 2022 Aug;82(2):212-222. doi: 10.1016/j.eururo.2022.04.013. Epub 2022 May 14.
Impact factor:
Publication type: Paper in international publication
Authors: Aleshin, Alexey; Assaf, Zoe June; Banchereau, Romain; Castellano, Daniel; Crabb, Simon J; Daelemans, Sofie; Duran, Ignacio; Gravis, Gwenaelle; Herranz, Urbano Anido; Kockx, Mark et al.
DOI: 10.1016/j.eururo.2022.04.013

Final Safety and Efficacy Results from a 106 Real-World Patients Registry with an Ascites-Mobilizing Pump.

PMID: 35686702
Journal: LIVER INTERNATIONAL
Year: 2022
Reference: Liver Int. 2022 Jun 10. doi: 10.1111/liv.15337.
Impact factor: 5.828
Publication type: Paper in international publication
Authors: Herber, Adam, Trepte, Claudia, Capel, Jeroen, De Gottardi, Andrea, Engelmann, Cornelius, Geier, Andreas, Vargas, Victor, Babatz, Jana, Stirnimann, Guido, Berg, Thomas et al.
DOI: 10.1111/liv.15337

Final Safety and Efficacy Results from a 106 Real-World Patients Registry with an Ascites-Mobilizing Pump.

PMID: 35686702
Journal: LIVER INTERNATIONAL
Year: 2022
Reference: Liver Int. 2022 Oct;42(10):2247-2259. doi: 10.1111/liv.15337. Epub 2022 Jul 25.
Impact factor:
Publication type: Paper in international publication
Authors: Babatz, Jana; Banz, Vanessa; Berg, Thomas; Capel, Jeroen; De Gottardi, Andrea; Engelmann, Cornelius; Geier, Andreas; Herber, Adam; Lammert, Frank; McPherson, Stuart et al.
DOI: 10.1111/liv.15337

Final safety and HRQoL results of the phase II/III Act.In.Sarc study with preoperative NBTXR3 plus radiotherapy versus radiotherapy in locally advanced soft-tissue sarcoma.

PMID: 35850363
Journal: INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOG
Year: 2022
Reference: Int J Radiat Oncol Biol Phys. 2022 Jul 15. pii: S0360-3016(22)00720-9. doi: 10.1016/j.ijrobp.2022.07.001.
Impact factor: 7.038
Publication type: Paper in international publication
Authors: Herraez, Antonio Casado; Tiangco, Beatrice J; Li, Rubi K; Moreno, Victor; Rastrelli, Marco; Mervoyer, Augustin; Sunyach, Marie-Pierre; Agoston, Peter; Ducassou, Anne; Carrere, Sebastien et al.
DOI: 10.1016/j.ijrobp.2022.07.001

Final safety and HRQoL results of the phase II/III Act.In.Sarc study with preoperative NBTXR3 plus radiotherapy versus radiotherapy in locally advanced soft-tissue sarcoma.

PMID: 35850363
Journal: INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
Year: 2022
Reference: Int J Radiat Oncol Biol Phys. 2022 Nov 1;114(3):422-432. doi: 10.1016/j.ijrobp.2022.07.001. Epub 2022 Jul 16.
Impact factor:
Publication type: Paper in international publication
Authors: Agoston, Peter; Anghel, Rodica M; Austen, Lyn; Bonvalot, Sylvie; Bovee, Judith V M G; Carrere, Sebastien; Cesne, Axel Le; de Baere, Thierry; Dimitriu, Mikaela; Ducassou, Anne et al.
DOI: 10.1016/j.ijrobp.2022.07.001

Fine Control of In Vivo Magnetic Hyperthermia Using Iron Oxide Nanoparticles with Different Coatings and Degree of Aggregation.

PMID: 35893782
Journal: Pharmaceutics
Year: 2022
Reference: Pharmaceutics. 2022 Jul 22;14(8). pii: pharmaceutics14081526. doi: 10.3390/pharmaceutics14081526.
Impact factor:
Publication type: Paper in international publication
Authors: Abasolo, Ibane; Artes-Ibanez, Emilio J; Diaz-Riascos, Zamira V; Garcia-Soriano, David; Ibarrola, Oihane; Luengo, Yurena; Miranda, Rodolfo; Salas, Gorka; Schwartz, Simo Jr; Somoza, Alvaro et al.
DOI: 10.3390/pharmaceutics14081526

First clinical multicenter experience with the new Pipeline Vantage flow diverter.

PMID: 35172983
Journal: Journal of NeuroInterventional Surgery
Year: 2022
Reference: J Neurointerv Surg. 2022 Feb 16. pii: neurintsurg-2021-018480. doi: 10.1136/neurintsurg-2021-018480.
Impact factor: 5.836
Publication type: Paper in international publication
Authors: Cekirge, H Saruhan, Vollherbst, Dominik F, Onal, Baran, Koc, Osman, Rautio, Riitta, Sinisalo, Matias, Tomasello, Alejandro, Vega, Pedro, Martinez-Galdamez, Mario, Lynch, Jeremy et al.
DOI: 10.1136/neurintsurg-2021-018480

First Description of Late-Onset Autoinflammatory Disease Due to Somatic NLRC4 Mosaicism.

PMID: 34672126
Journal: Arthritis & Rheumatology
Year: 2022
Reference: Arthritis Rheumatol. 2022 Apr;74(4):692-699. doi: 10.1002/art.41999. Epub 2022 Feb 14.
Impact factor: 10.995
Publication type: Paper in international publication
Authors: Ionescu, Daniela, Penin-Franch, Alejandro, Mensa-Vilaro, Anna, Castillo, Paola, Hurtado-Navarro, Laura, Molina-Lopez, Cristina, Romero-Chala, Silvia, Plaza, Susana, Fabregat, Virginia, Bujan, Segundo et al.
DOI: 10.1002/art.41999

First Description of Late-Onset Autoinflammatory Disease Due to Somatic NLRC4 Mosaicism.

PMID: 34672126
Journal: Arthritis & Rheumatology
Year: 2022
Reference: Arthritis Rheumatol. 2022 Apr;74(4):692-699. doi: 10.1002/art.41999. Epub 2022 Feb 14.
Impact factor:
Publication type: Paper in international publication
Authors: Arostegui, Juan I; Bujan, Segundo; Casals, Ferran; Castillo, Paola; Fabregat, Virginia; Fernandez-Pereira, Luis Miguel; Hurtado-Navarro, Laura; Ionescu, Daniela; Marques, Joana; Mensa-Vilaro, Anna et al.
DOI: 10.1002/art.41999

First documented outbreak of arthritis caused by Kingella kingae in a Spanish childcare center.

PMID: 35241399
Journal: ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA
Year: 2022
Reference: Enferm Infecc Microbiol Clin (Engl Ed). 2022 Apr;40(4):187-189. doi: 10.1016/j.eimce.2022.02.004. Epub 2022 Feb 28.
Impact factor: 1.731
Publication type: Paper in international publication
Authors: Villalobos, Pilar, Garcia-Gonzalez, Maria Del Mar, Guarch-Ibanez, Borja, Cabacas, Alicia, Gonzalez-Lopez, Juan Jose, Mora, Carme et al.
DOI: 10.1016/j.eimce.2022.02.004

First documented outbreak of arthritis caused by Kingella kingae in a Spanish childcare center.

PMID: 35241399
Journal: ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA
Year: 2022
Reference: Enferm Infecc Microbiol Clin. 2022 Apr;40(4):187-189. doi: 10.1016/j.eimce.2022.02.004. Epub 2022 Feb 28.
Impact factor:
Publication type: Paper in national publication
Authors: Cabacas, Alicia; Garcia-Gonzalez, Maria Del Mar; Gonzalez-Lopez, Juan Jose; Guarch-Ibanez, Borja; Mora, Carme; Villalobos, Pilar et al.
DOI: 10.1016/j.eimc.2020.11.006

First pass effect in posterior circulation occlusions: analysis from the cicat registry.

PMID: 35272563
Journal: International Journal of Stroke
Year: 2022
Reference: Int J Stroke. 2022 Apr 20:17474930221089772. doi: 10.1177/17474930221089772.
Impact factor: 5.266
Publication type: Paper in international publication
Authors: Terceno, Mikel, Chamorro, Angel, Perez de la Ossa, Natalia, Hernandez-Perez, Maria, Castano, C, Camps-Renom, Pol, Wenger, Denisse, Cardona, Pere, Molina, Carlos, Rodriguez-Campello, Ana et al.
DOI: 10.1177/17474930221089772

First-in-human, open-label, phase 1/2 study of the monoclonal antibody programmed cell death protein-1 (PD-1) inhibitor cetrelimab (JNJ-63723283) in patients with advanced cancers.

PMID: 35298698
Journal: CANCER CHEMOTHERAPY AND PHARMACOLOGY
Year: 2022
Reference: Cancer Chemother Pharmacol. 2022 Apr;89(4):499-514. doi: 10.1007/s00280-022-04414-6. Epub 2022 Mar 17.
Impact factor: 3.333
Publication type: Paper in international publication
Authors: Felip, Enriqueta, Curigliano, Giuseppe, Rutkowski, Piotr, Trigo, Jose Manuel, Calvo, Aitana, Kowalski, Dariusz, Cortinovis, Diego, Plummer, Ruth, Maio, Michele, Ascierto, Paolo A et al.
DOI: 10.1007/s00280-022-04414-6

First-in-human, open-label, phase 1/2 study of the monoclonal antibody programmed cell death protein-1 (PD-1) inhibitor cetrelimab (JNJ-63723283) in patients with advanced cancers.

PMID: 35298698
Journal: CANCER CHEMOTHERAPY AND PHARMACOLOGY
Year: 2022
Reference: Cancer Chemother Pharmacol. 2022 Apr;89(4):499-514. doi: 10.1007/s00280-022-04414-6. Epub 2022 Mar 17.
Impact factor:
Publication type: Paper in international publication
Authors: Ascierto, Paolo A; Attiyeh, Edward; Bandyopadhyay, Nibedita; Calvo, Aitana; Calvo, Emiliano; Cervantes, Andres; Cortinovis, Diego; Curigliano, Giuseppe; Felip, Enriqueta; Greger, James G et al.
DOI: 10.1007/s00280-022-04414-6

First-in-man histotripsy of hepatic tumors: the THERESA trial, a feasibility study.

PMID: 36002243
Journal: INTERNATIONAL JOURNAL OF HYPERTHERMIA
Year: 2022
Reference: Int J Hyperthermia. 2022;39(1):1115-1123. doi: 10.1080/02656736.2022.2112309.
Impact factor:
Publication type: Paper in international publication
Authors: Amaral, Joseph; Bolduan, Ryan; Cannata, Jon; Duryea, Alex; Hall, Timothy; Kam, Yossi; Lee, Fred T Jr; Merino, Xavier; Miller, Ryan; Serres, Xavier et al.
DOI: 10.1080/02656736.2022.2112309

First-line trifluridine/tipiracil + bevacizumab in patients with unresectable metastatic colorectal cancer: final survival analysis in the TASCO1 study.

PMID: 35440667
Journal: BRITISH JOURNAL OF CANCER
Year: 2022
Reference: Br J Cancer. 2022 Jun;126(11):1548-1554. doi: 10.1038/s41416-022-01737-2. Epub 2022 Apr 19.
Impact factor: 7.64
Publication type: Paper in international publication
Authors: Van Cutsem, E, Danielewicz, I, Saunders, M P, Pfeiffer, P, Argiles, G, Borg, C, Glynne-Jones, R, Punt, C J A, Van de Wouw, A J, Fedyanin, M et al.
DOI: 10.1038/s41416-022-01737-2

First-line trifluridine/tipiracil + bevacizumab in patients with unresectable metastatic colorectal cancer: final survival analysis in the TASCO1 study.

PMID: 35440667
Journal: BRITISH JOURNAL OF CANCER
Year: 2022
Reference: Br J Cancer. 2022 Jun;126(11):1548-1554. doi: 10.1038/s41416-022-01737-2. Epub 2022 Apr 19.
Impact factor:
Publication type: Paper in international publication
Authors: Amellal, N; Argiles, G; Borg, C; Danielewicz, I; Egorov, A; Falcone, A; Fedyanin, M; Fougeray, R; Garcia-Alfonso, P; Glynne-Jones, R et al.
DOI: 10.1038/s41416-022-01737-2

First-trimester screening for preeclampsia and small-for-gestational-age: A comparison of the Gaussian and FMF algorithms.

PMID: 35695395
Journal: INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS
Year: 2022
Reference: Int J Gynaecol Obstet. 2022 Jun 13. doi: 10.1002/ijgo.14306.
Impact factor: 3.561
Publication type: Paper in international publication
Authors: Carreras, Elena, Mendoza, Manel, Armengol-Alsina, Mireia, Perestelo, Ana, Murcia, Maria Teresa, Serrano, Berta, Bonacina, Erika, Rodo, Carlota, Garcia-Manau, Pablo, Sanchez-Duran, Maria Angeles et al.
DOI: 10.1002/ijgo.14306